ATE517614T1 - Pflaster enthaltend einen anti-inflammatorischen wirkstoff - Google Patents

Pflaster enthaltend einen anti-inflammatorischen wirkstoff

Info

Publication number
ATE517614T1
ATE517614T1 AT01919982T AT01919982T ATE517614T1 AT E517614 T1 ATE517614 T1 AT E517614T1 AT 01919982 T AT01919982 T AT 01919982T AT 01919982 T AT01919982 T AT 01919982T AT E517614 T1 ATE517614 T1 AT E517614T1
Authority
AT
Austria
Prior art keywords
mass
test
active ingredient
antiinflammatory
molecular weight
Prior art date
Application number
AT01919982T
Other languages
English (en)
Inventor
Yasuhiro Ikeura
Miyuki Shinmura
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE517614T1 publication Critical patent/ATE517614T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01919982T 2000-04-18 2001-04-17 Pflaster enthaltend einen anti-inflammatorischen wirkstoff ATE517614T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000116744 2000-04-18
PCT/JP2001/003283 WO2001078690A1 (en) 2000-04-18 2001-04-17 Patch containing anti-inflammatory agent

Publications (1)

Publication Number Publication Date
ATE517614T1 true ATE517614T1 (de) 2011-08-15

Family

ID=18628168

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01919982T ATE517614T1 (de) 2000-04-18 2001-04-17 Pflaster enthaltend einen anti-inflammatorischen wirkstoff

Country Status (13)

Country Link
US (2) US20030149383A1 (de)
EP (1) EP1277466B1 (de)
JP (1) JP4854163B2 (de)
KR (1) KR100600456B1 (de)
CN (1) CN1200696C (de)
AT (1) ATE517614T1 (de)
BR (1) BR0110178A (de)
CA (1) CA2406261C (de)
DK (1) DK1277466T3 (de)
ES (1) ES2367541T3 (de)
PT (1) PT1277466E (de)
TW (1) TWI283587B (de)
WO (1) WO2001078690A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001043729A1 (fr) * 1999-12-15 2001-06-21 Hisamitsu Pharmaceutical Co., Inc. Preparations d'adhesifs
FR2838745B1 (fr) * 2002-04-17 2004-07-09 Urgo Laboratoires Emulsions solides a base d'elastomere thermoplastique
AU2003272878A1 (en) * 2002-09-13 2004-04-30 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
US8034374B2 (en) * 2003-03-18 2011-10-11 Hisamitsu Pharmaceutical Co., Inc. Patch containing nonsteroidal anti-inflammatory and analgesic agent
TWI327074B (en) * 2003-05-07 2010-07-11 Hisamitsu Pharmaceutical Co Ultra violet shielding patch
US7476222B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of reducing the appearance of pigmentation with galvanic generated electricity
BRPI0415652B8 (pt) * 2003-10-20 2021-07-27 Hisamitsu Pharmaceutical Co composição adesiva sensível à pressão
DE10357321A1 (de) 2003-12-05 2005-07-21 Tesa Ag Hochtackige Klebmasse, Verfahren zu deren Herstellung und deren Verwendung
TWI341736B (en) 2003-12-26 2011-05-11 Hisamitsu Pharmaceutical Co Anti-infammatory adhesive preparations
TW200613004A (en) * 2004-08-31 2006-05-01 Aspion Co Ltd External preparation of solid/oil type
KR101121890B1 (ko) * 2004-11-05 2012-03-19 리도 케미칼 가부시키가이샤 비스테로이드 소염 진통약을 함유하는 비수계 경피흡수제제
JP4869583B2 (ja) * 2004-11-30 2012-02-08 久光製薬株式会社 角質剥離が少ない貼付剤
JP2006206471A (ja) * 2005-01-26 2006-08-10 Nitto Denko Corp テープ製剤
JP5117846B2 (ja) * 2005-02-25 2013-01-16 久光製薬株式会社 抗炎症剤及び大豆レシチンを含有する外用剤
BRPI0607464B8 (pt) * 2005-03-10 2021-06-22 Hisamitsu Pharmaceutical Co adesivo e emplastro adesivo
US20060263420A1 (en) * 2005-03-10 2006-11-23 Hisamitsu Pharmaceutical Co., Inc. Adhesive and plaster
JP5089376B2 (ja) * 2005-03-10 2012-12-05 久光製薬株式会社 粘着剤及び貼付剤
JP4921739B2 (ja) * 2005-08-10 2012-04-25 久光製薬株式会社 皮膚刺激を低減した貼付剤
JP5684441B2 (ja) * 2005-12-28 2015-03-11 久光製薬株式会社 インドメタシン含有貼付剤
CN101896175B (zh) * 2007-12-12 2013-03-13 帝国制药株式会社 含有环氧洛芬的水性贴剂
CN101502499B (zh) * 2009-03-13 2011-07-27 北京化工大学 一种布洛芬经皮释放贴剂及其制备方法
CN102933209B (zh) * 2010-04-13 2015-06-17 东亚合成株式会社 医疗用粘合剂组合物、医疗用贴剂和该组合物的制备方法
JP6014813B2 (ja) * 2010-09-03 2016-10-26 株式会社 ケイ・エム トランスダーム 経皮吸収製剤および皮膚貼付用粘着シート
ES2669306T3 (es) * 2010-11-02 2018-05-24 Teikoku Seiyaku Co., Ltd. Parche externo que contiene felbinaco
CN103849100A (zh) * 2012-12-03 2014-06-11 中国石油化工股份有限公司 一种用于膏药或贴剂的载体苯乙烯-异戊二烯嵌段共聚组合物及胶粘剂的制备
JP5767417B1 (ja) 2015-02-05 2015-08-19 久光製薬株式会社 貼付剤
CN106692110B (zh) * 2015-08-19 2019-12-17 天津市山佳医药科技有限公司 一种芳基丙酸类非甾体抗炎药贴剂及其制备方法
CN106692111A (zh) * 2015-11-13 2017-05-24 北京泰德制药股份有限公司 一种含有酮洛芬的皮肤外用贴剂及其制备方法
CN106822049B (zh) * 2015-12-07 2020-10-20 北京乳凝创智生物技术研发中心（有限合伙） 新型化药贴剂酮洛芬贴片及其制备方法
EP3301133A1 (de) 2016-09-29 2018-04-04 ARLANXEO Canada Inc. Multimodale polyisoolefinzusammensetzungen und verfahren zu ihrer herstellung
EP3528795A1 (de) * 2016-10-18 2019-08-28 LTS Lohmann Therapie-Systeme AG Zweischichtiges topisches therapeutisches system
ES2893527T3 (es) 2016-12-28 2022-02-09 Hisamitsu Pharmaceutical Co Parche
US11872320B2 (en) 2021-02-25 2024-01-16 Hisamitsu Pharmaceutical Co., Inc. Method for treating osteoarthritis
US20230120384A1 (en) * 2021-10-19 2023-04-20 Heather Sloan Menthol- and magnesium-infused kinesiology tape
DE102021128912A1 (de) * 2021-11-05 2023-05-11 Lts Lohmann Therapie-Systeme Ag. Okklusives pflaster mit flexibler backing
CN117159508B (zh) * 2023-09-18 2024-11-15 湖南九典制药股份有限公司 热熔型贴剂及其制备方法
CN120346189B (zh) * 2025-06-23 2025-09-16 杭州百诚医药科技股份有限公司 一种热熔型洛索洛芬钠贴剂及其制备方法
CN121081428B (zh) * 2025-11-11 2026-02-13 湖南迪诺制药股份有限公司 一种高稳定性氟比洛芬抗炎贴剂及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158609A (en) * 1975-09-23 1979-06-19 Mueller Hans Process for the continuous conversion of products by enzyme action
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル
JPS5951215A (ja) 1982-09-14 1984-03-24 Taisho Pharmaceut Co Ltd 粘着性湿布剤
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
JPS6440420A (en) 1987-08-04 1989-02-10 Hisamitsu Pharmaceutical Co Anti-inflammatory and analgesic tape agent for percutaneous administration
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
US5750134A (en) * 1989-11-03 1998-05-12 Riker Laboratories, Inc. Bioadhesive composition and patch
CA2072623C (en) * 1989-11-03 2001-03-27 Matthew T. Scholz Bioadhesive composition and patch
AU637496B2 (en) * 1990-04-24 1993-05-27 Teijin Limited Plaster
US5633192A (en) * 1991-03-18 1997-05-27 Boston University Method for epitaxially growing gallium nitride layers
EP0607434B1 (de) * 1991-08-30 1999-01-27 Hisamitsu Pharmaceutical Co., Inc. Entzündungshemmendes, analgetisches pflaster
JPH05331064A (ja) 1992-05-26 1993-12-14 Sekisui Chem Co Ltd 消炎鎮痛貼付剤
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
AU676562B2 (en) * 1993-05-19 1997-03-13 Hisamitsu Pharmaceutical Co., Inc. Solubilizing agent and external preparation containing the same
DE69526437T2 (de) * 1994-05-18 2002-10-31 Hisamitsu Pharmaceutical Co., Inc. Transdermal verabreichbare zubereitung zur behandlung von störungen des harnlassens
US5869087A (en) 1994-09-16 1999-02-09 Hisamitsu Pharmaceutical Co., Inc. Patch having a preparation for external use attached thereto
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
DE69738825D1 (de) 1996-12-06 2008-08-21 Hisamitsu Pharmaceutical Co Felbinac enthaltendes Pflaster
KR19990026792A (ko) 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
WO2001043729A1 (fr) * 1999-12-15 2001-06-21 Hisamitsu Pharmaceutical Co., Inc. Preparations d'adhesifs
US6914169B1 (en) * 2000-05-19 2005-07-05 Hisamitsu Pharmaceutical., Inc. Patch agent
CA2411950A1 (en) * 2000-06-13 2002-12-09 Hisamitsu Pharmaceutical Co., Inc. Patch

Also Published As

Publication number Publication date
CN1424908A (zh) 2003-06-18
KR100600456B1 (ko) 2006-07-13
EP1277466A1 (de) 2003-01-22
DK1277466T3 (da) 2011-10-17
JP4854163B2 (ja) 2012-01-18
CA2406261C (en) 2010-12-07
KR20020089476A (ko) 2002-11-29
CA2406261A1 (en) 2002-10-17
TWI283587B (en) 2007-07-11
US20090258952A1 (en) 2009-10-15
US8173156B2 (en) 2012-05-08
US20030149383A1 (en) 2003-08-07
ES2367541T3 (es) 2011-11-04
EP1277466A4 (de) 2008-08-20
EP1277466B1 (de) 2011-07-27
WO2001078690A1 (en) 2001-10-25
CN1200696C (zh) 2005-05-11
BR0110178A (pt) 2003-12-30
PT1277466E (pt) 2011-09-01

Similar Documents

Publication Publication Date Title
PT1277466E (pt) Emplastro contendo agente anti-inflamatório
PE20030399A1 (es) Formas de administracion de propiverina o sus sales farmaceuticamente aceptables con liberacion prolongada de la sustancia activa
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
NO20052479L (no) Tramadolformuleringer med forsinket frigjoring og 24 timers effektivitet
HUP0100801A2 (hu) Metformin és fibrát kombinációját tartalmazó gyógyászati készítmények és ezek alkalmazása kórosan magas vércukorszint csökkentését célzó gyógyszerek előállítására
NO20051854L (no) Vedvarende frigivelse opioidformuleringer og fremgangsmater for anvendelse.
TR200103693T2 (tr) Yeni formülasyon
DK1185253T3 (da) Oralt præparat til indgivelse af en fast kombination af tramadol og diclofenac
ES2194732T3 (es) Composiciones farmaceuticas orales de liberacion controlada de mesalazina.
NO20043913L (no) Blandinger med modifisert frigjoring av i det minste en form av tramadol
DK0841904T3 (da) Orale farmaceutiske præparater med forsinket frigivelse af reversible protonpumpeinhibitorer
UA84266C2 (uk) Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування
WO2003086369A3 (en) Stealthy polymeric biodegradable nanospheres and uses thereof
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
BR0307060A (pt) ésteres hidroxamato do ácido n-(fenil 4-substituìdo)-antranìlico
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
SE0402762D0 (sv) Indazole sulphonamide derivatives
ATE357928T1 (de) Pharmazeutische zusammensetzung für thrombinpeptidderivaten
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
CA2415154A1 (en) Modified release formulations of selective serotonin re-uptake inhibitors
BRPI0507735A (pt) composição para administração oral de cloridrato de tamsulosin e formulação de gránulo de liberação controlada compreendendo a mesma
DK1300143T3 (da) Plaster som indeholder 4-biphenyleddikesyre
NO983444L (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
EP1072261A3 (de) Felbinac enthaltendes Pflaster
SE0001916D0 (sv) Novel formulation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties